Ulixertinib, also known as BVD-523 and VRT752271, is an inhibitors of ERK protein kinase. Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis.
仅供研究使用。 我们不向患者出售。
化学信息
| 名称 | Ulixertinib HCl |
| Iupac 化学名称 | (S)-4-(5-chloro-2-(isopropylamino)pyridin-4-yl)-N-(1-(3-chlorophenyl)-2-hydroxyethyl)-1H-pyrrole-2-carboxamide hydrochloride. |
| 同义词 | BVD-523; BVD 523; BVD523; VRT752271; VRT752271; VRT 752271; Ulixertinib hydrochloride. |
| 英文同义词 | BVD-523; BVD 523; BVD523; VRT752271; VRT752271; VRT 752271; Ulixertinib hydrochloride. |
| 分子式 | C21H23Cl3N4O2 |
| 分子量 | 469.791 |
| InChiKey | |
| InChi | |
| Cas号 | 1956366-10-1 |
| 相关CAS号 | |
| 外观性状 | off-white solid |
| 纯度 | 98.0% |
| 存储 | -20 ℃ for 3 years |
| 可溶性 | Soluble in DMSO |
| 处理方式 | |
| 运输条件 | Shipped under ambient temperature as non-hazardous chemical. |
| 海关编码 | |
| Targets | |
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study | |